Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Employer workforce profile
0
0
$160,299
256
2023
0
All certified DOL LCAs in the warehouse (FY2024 Q1–FY2026 Q2), newest received first.
| Role | BatchBatch | WageOffered wage | DateReceived |
|---|---|---|---|
| Associate Scientist Bioscience | FY 2024 Q3 | $88,400/yr | May 3 '24May 3, 2024 |
| Sr. Manager, Incentives and Awards, Oncology | FY 2024 Q3 | $166,400/yr | Apr 29 '24Apr 29, 2024 |
| Associate Director - Oncology R&D | FY 2024 Q3 | $163,200/yr | Apr 24 '24Apr 24, 2024 |
| Senior Scientist | FY 2024 Q3 | $124,500/yr | Apr 24 '24Apr 24, 2024 |
| Scientist - TCR Discovery | FY 2024 Q3 | $96,720/yr | Apr 24 '24Apr 24, 2024 |
| Senior Scientist Medicinal Chemist, Early Oncology | FY 2024 Q3 | $121,973/yr | Apr 23 '24Apr 23, 2024 |
| Senior Scientist | FY 2024 Q3 | $128,071/yr | Apr 22 '24Apr 22, 2024 |
| Senior Scientist, Cell Therapy | FY 2024 Q3 | $109,180/yr | Apr 22 '24Apr 22, 2024 |
| Senior Statistician | FY 2024 Q3 | $151,424/yr | Apr 19 '24Apr 19, 2024 |
| In Vivo Senior Scientist, Oncology Biosciences | FY 2024 Q3 | $125,661/yr | Apr 19 '24Apr 19, 2024 |
| Associate Director, Reporting Strategy & Design | FY 2024 Q3 | $172,500/yr | Apr 18 '24Apr 18, 2024 |
| Senior Scientist, Cell Therapy | FY 2024 Q3 | $110,838/yr | Apr 18 '24Apr 18, 2024 |
| Associate Director | FY 2024 Q3 | $165,465/yr | Apr 17 '24Apr 17, 2024 |
| Senior Scientist Cryobiology | FY 2024 Q3 | $118,450/yr | Apr 17 '24Apr 17, 2024 |
| Statistician I | FY 2024 Q3 | $114,400/yr | Apr 16 '24Apr 16, 2024 |
| Senior Patient Safety Specialist | FY 2024 Q2 | $125,258/yr | Mar 20 '24Mar 20, 2024 |
| Forecasting Director, Oncology | FY 2024 Q2 | $235,098/yr | Mar 19 '24Mar 19, 2024 |
| Brand Analytics Senior Manager | FY 2024 Q2 | $159,303/yr | Mar 18 '24Mar 18, 2024 |
| Brand Analytics Senior Manager | FY 2024 Q2 | $159,303/yr | Mar 18 '24Mar 18, 2024 |
| Project Manager | FY 2024 Q2 | $148,400/yr | Mar 8 '24Mar 8, 2024 |
| Value Strategies Lead Early Assets and Lynparza– Oncology | FY 2024 Q2 | $192,000/yr | Mar 7 '24Mar 7, 2024 |
| CMC Regulatory Affairs Associate Director | FY 2024 Q2 | $157,669/yr | Mar 7 '24Mar 7, 2024 |
| Associate Principal Scientist, InVitro Oncology R&D | FY 2024 Q2 | $157,529/yr | Mar 6 '24Mar 6, 2024 |
| Director Quality | FY 2024 Q2 | $185,153/yr | Mar 5 '24Mar 5, 2024 |
| Director Quality | FY 2024 Q2 | $185,153/yr | Mar 5 '24Mar 5, 2024 |
| Veeva Clinical Vault IT Product Lead | FY 2024 Q2 | $190,595/yr | Mar 4 '24Mar 4, 2024 |
| Analytics Sr. Manager, US Oncology | FY 2024 Q2 | $140,857/yr | Mar 4 '24Mar 4, 2024 |
| Associate Director | FY 2024 Q2 | $148,824/yr | Feb 29 '24Feb 29, 2024 |
| Engineer II | FY 2024 Q2 | $126,006/yr | Feb 29 '24Feb 29, 2024 |
| Director, Systems Medicine | FY 2024 Q2 | $200,000/yr | Feb 20 '24Feb 20, 2024 |
| Scientist | FY 2024 Q2 | $101,519/yr | Feb 13 '24Feb 13, 2024 |
| Scientist | FY 2024 Q2 | $101,519/yr | Feb 13 '24Feb 13, 2024 |
| Product Engineering Lead | FY 2024 Q2 | $188,478/yr | Feb 7 '24Feb 7, 2024 |
| Statistical Programming Associate Director | FY 2024 Q2 | $156,255/yr | Jan 31 '24Jan 31, 2024 |
| Scientist – Hybridoma Technology | FY 2024 Q2 | $98,000/yr | Jan 26 '24Jan 26, 2024 |
| Global Labeling Strategy Director | FY 2024 Q2 | $220,000/yr | Jan 16 '24Jan 16, 2024 |
| Global Insights and Forecasting Leader - Early Assets | FY 2024 Q2 | $200,000/yr | Jan 16 '24Jan 16, 2024 |
| Global Insights and Forecasting Leader – Early Assets | FY 2024 Q2 | $200,000/yr | Jan 11 '24Jan 11, 2024 |
| Engineer II | FY 2024 Q2 | $96,130/yr | Jan 10 '24Jan 10, 2024 |
| Scientist, Cell Therapy | FY 2024 Q1 | $94,500/yr | Dec 15 '23Dec 15, 2023 |
| Portfolio & Capacity Management, Manager | FY 2024 Q1 | $92,800/yr | Dec 7 '23Dec 7, 2023 |
| Director, Patient Safety Technical Solutions | FY 2024 Q1 | $151,264/yr | Nov 30 '23Nov 30, 2023 |
| Associate Director Marketing, PM Breast Cancer | FY 2024 Q1 | $170,686/yr | Nov 16 '23Nov 16, 2023 |
| Statistical Science Director | FY 2024 Q1 | $210,698/yr | Nov 9 '23Nov 9, 2023 |
| Global Forecasting Leader (Director) | FY 2024 Q1 | $192,400/yr | Nov 9 '23Nov 9, 2023 |
| Sr. Statistical Scientist II - Late CVRM | FY 2024 Q1 | $160,000/yr | Nov 9 '23Nov 9, 2023 |
| Director DS & AI Product, Oncology | FY 2024 Q1 | $190,000/yr | Nov 6 '23Nov 6, 2023 |
| Director, Quality Science and Processes | FY 2024 Q1 | $175,802/yr | Nov 6 '23Nov 6, 2023 |
| Manager, Global Labelling Delivery | FY 2024 Q1 | $122,596/yr | Nov 6 '23Nov 6, 2023 |
| Platform Engineer – SalesForce | FY 2024 Q1 | $150,000/yr | Nov 1 '23Nov 1, 2023 |